Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection

[1]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[2]  J. Bastarache,et al.  Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS , 2017, Chest.

[3]  Sumana Sanyal,et al.  Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection , 2017, The Journal of Biological Chemistry.

[4]  M. Lennon,et al.  Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition. , 2016, American journal of respiratory and critical care medicine.

[5]  Jin Hyang Kim,et al.  Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus , 2016, PloS one.

[6]  T. Narasaraju,et al.  Neutrophils as Possible Therapeutic Targets in Severe Influenza Pneumonia , 2016, Journal of infectious pulmonary diseases.

[7]  T. van der Poll,et al.  Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis. , 2016, JAMA.

[8]  L. Kobzik,et al.  Influenza lung injury: mechanisms and therapeutic opportunities. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[9]  Zhan-Qiu Yang,et al.  The cytokine storm of severe influenza and development of immunomodulatory therapy , 2015, Cellular and Molecular Immunology.

[10]  Yuejin Wu,et al.  Correction: Corrigendum: The mitochondrial uniporter controls fight or flight heart rate increases , 2015, Nature Communications.

[11]  C. Shaw,et al.  Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections – A Prospective Cohort Study , 2015, PLoS pathogens.

[12]  Paul G. Thomas,et al.  Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells , 2015, Nature Communications.

[13]  S. Pocock,et al.  Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials , 2015, The Lancet.

[14]  Christine E. Becker,et al.  Influenza virus-induced lung injury: pathogenesis and implications for treatment , 2015, European Respiratory Journal.

[15]  N. Vorobjeva,et al.  Neutrophil Extracellular Traps: Mechanisms of formation and role in health and disease , 2014, Biochemistry (Moscow).

[16]  D. Grimaldi,et al.  Post-infectious immune suppression: a new paradigm of severe infections. , 2014, Medecine et maladies infectieuses.

[17]  Anne M Johnson,et al.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study , 2014, The Lancet Respiratory Medicine.

[18]  Klaus Schughart,et al.  Influenza A immunomics and public health omics: the dynamic pathway interplay in host response to H1N1 infection. , 2014, Omics : a journal of integrative biology.

[19]  N SgarbasKyriakos,et al.  Influenza A immunomics and public health omics: the dynamic pathway interplay in host response to H1N1 infection. , 2014 .

[20]  Jonathan J Deeks,et al.  Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.

[21]  Frederick Klauschen,et al.  A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection , 2013, Cell.

[22]  A. Zangrillo,et al.  Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO , 2013, Critical Care.

[23]  L. Carin,et al.  A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2 , 2013, PloS one.

[24]  Mark A. Ragan,et al.  Supervised, semi-supervised and unsupervised inference of gene regulatory networks , 2013, Briefings Bioinform..

[25]  Wenlin Huang,et al.  Influenza A Virus NS1 Induces G0/G1 Cell Cycle Arrest by Inhibiting the Expression and Activity of RhoA Protein , 2013, Journal of Virology.

[26]  T. Braciale,et al.  Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells , 2012, PloS one.

[27]  Stephen J. Huang,et al.  A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia , 2012, Critical Care.

[28]  J. Oxford,et al.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.

[29]  F. Venet,et al.  Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions , 2011, Critical care.

[30]  Christl A. Donnelly,et al.  Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis , 2011, PLoS medicine.

[31]  N. Van Rooijen,et al.  Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis , 2011, The American Journal of Pathology.

[32]  Stephen Huang,et al.  Aberrant Cell Cycle and Apoptotic Changes Characterise Severe Influenza A Infection – A Meta-Analysis of Genomic Signatures in Circulating Leukocytes , 2011, PloS one.

[33]  F. Krebs,et al.  Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection , 2011, Antimicrobial Agents and Chemotherapy.

[34]  Ke Xu,et al.  Influenza A Virus Replication Induces Cell Cycle Arrest in G0/G1 Phase , 2010, Journal of Virology.

[35]  Wei Zhao,et al.  Weighted Gene Coexpression Network Analysis: State of the Art , 2010, Journal of biopharmaceutical statistics.

[36]  Yan Zhou,et al.  The functional impairment of natural killer cells during influenza virus infection , 2009, Immunology and cell biology.

[37]  L. Carin,et al.  Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. , 2009, Cell host & microbe.

[38]  D. Fedson.  Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work , 2009, Influenza and other respiratory viruses.

[39]  T. Braciale,et al.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.

[40]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[41]  D. Stroncek.  Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177 , 2007, Current opinion in hematology.

[42]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[43]  Yan Li,et al.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.

[44]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[45]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[46]  G. Rubin,et al.  Effect of heat shock on the synthesis of low molecular weight RNAs in drosophila: Accumulation of a novel form of 5S RNA , 1975, Cell.

[47]  J. Teijaro.  The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. , 2015, Current topics in microbiology and immunology.

[48]  T. Kuiken,et al.  Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.